Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLRMT | O00411 | 1/20 | 0.32 |
| ▸ | PIK3CD | O00329 | 5/20 | 0.32 |
| ▸ | TMPRSS2 | O15393 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24789794 | 0.85 | PIK3CD (0.34) | PIK3CDTMPRSS2 | |
| SCHEMBL10141879 | 0.85 | POLRMT (0.47) | POLRMT | |
| SCHEMBL10142076 | 0.84 | TMPRSS2 (0.36) | PIK3CDTMPRSS2 | |
| SCHEMBL4970753 | 0.84 | TMPRSS2 (0.36) | PIK3CDTMPRSS2 | |
| SCHEMBL18666907 | 0.84 | TMPRSS2 (0.36) | PIK3CDTMPRSS2 | |
| SCHEMBL24790497 | 0.84 | PIK3CD (0.33) | PIK3CDTMPRSS2 | |
| SCHEMBL29566128 | 0.84 | TMPRSS2 (0.32) | PIK3CDTMPRSS2 | |
| SCHEMBL25608306 | 0.83 | PIK3CD (0.31) | PIK3CD | |
| SCHEMBL4972175 | 0.83 | PIK3CD (0.32) | PIK3CD | |
| SCHEMBL27121333 | 0.83 | TMPRSS2 (0.32) | PIK3CDTMPRSS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230147364-A1 | PROPHYLACTIC OR THERAPEUTIC AGENT FOR RNA VIRUS-RELATED DISEASES | KYOTO UNIVERSITY (JP) | 2023-05-11 | — | — | US | disclosed |
| WO-2022123501-A1 | PROTECTED DEOXYDIDEHYDRO-NUCLEOSIDES | VICTORIA LINK LIMITED (NZ) | 2022-06-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230147364-A1 | PROPHYLACTIC OR THERAPEUTIC AGENT FOR RNA VIRUS-RELATED DISEASES | CYSLTR1, ALOX5, ALOX15 | POLRMT 200/4885PIK3CD 4783/4885TMPRSS2 129/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.